Yingu Pharmaceutical

China-based Shandong Saito Bio-Technology Co., Ltd. (SHE: 300583) has announced plans to acquire a 60% stake in fellow Chinese firm Yingu Pharmaceutical Co., Ltd for RMB 458.1 million (USD 62.7 million) in cash. Upon the deal’s closure, Saito will emerge as Yingu’s controlling shareholder, marking a significant strategic move in…